Medical device security firm Medigate announced today that it completed a $30 million Series B financing round.
New York-based Medigate’s funding round was led by new investor Partech, with participation from existing investors YL Ventures, U.S. Venture Partners and Blumberg Capital and new investor Maor Investments. The $30 million brings Medigate’s total funding to $50 million to date, according to a news release.
The company plans to use the investment to continue growing as it seeks to become healthcare’s security and clinical analytics company, providing a single, comprehensive solution for organizations expanding their digital strategies.
Medigate develops a solution designed to address patient safety and privacy by automatically locating, identifying and managing the security posture of all devices connected to a network, along with powering clinical engineering through device data.
“Partech is a very sophisticated technology investor. With their backing, we will be able to quickly expand to help healthcare organizations around the world experience the same ROI as those in the United States,” Medigate CEO & co-founder Jonathan Langer said in the release. “We are very appreciative of the continued support we receive from our investors at YL Ventures, USVP and Blumberg Capital and are excited to add Partech and Maor Investments to our team as we enter in the next phase of our growth.”